July 12, 2012
Taiho Pharmaceutical and Teikoku Seiyaku announced on July 11 that they have agreed to form a business alliance for the cancer pain reliever OVF (fentanyl citrate buccal tablet), which is being developed by Taiho. Under the alliance, Teikoku will submit...read more